Hereditary sensory and autonomic neuropathy
MONDO:0015364An instance of sensory peripheral neuropathy that is caused by an inherited modification of the individual's genome.
Also known as: CIP, HSAN, congenital insensitivity to pain, congenital pain insensitivity, hereditary sensory and autonomic neuropathy, hereditary sensory neuropathy, hereditary sensory peripheral neuropathy, indifference to pain, Congenital, autosomal recessive
51 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Simple exercises may boost nerve repair in diabetic neuropathy
Disease control Not yet recruitingThis study compares two exercise programs—combined aerobic and resistance training versus seated soleus push-ups—against standard care in people with type 2 diabetes and diabetic peripheral neuropathy. Researchers will measure blood markers of nerve repair (BDNF, NGF, S100B) and …
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat uterine cancer
Disease control Not yet recruitingThis phase 2 trial is testing a daily pill called Inavolisib in about 48 people with advanced endometrial cancer that has a specific genetic change (PIK3CA mutation). The drug targets that mutation to try to shrink tumors or stop them from growing. Researchers will measure how ma…
Phase: PHASE2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a worm enzyme soothe diabetic nerve damage?
Symptom relief Not yet recruitingThis study tests whether an oral supplement called DLBS1033 (made from earthworm proteins) can reduce nerve damage symptoms in adults with diabetic polyneuropathy. Thirty-four people with type 2 diabetes will receive either the supplement or a placebo for 28 days, alongside stand…
Phase: PHASE2, PHASE3 • Sponsor: Universitas Sebelas Maret • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Gene therapy readiness check: new study maps virus immunity in muscle disease patients
Knowledge-focused Not yet recruitingThis study will test blood samples from 450 people aged 6 to 60 with inherited neuromuscular diseases to see if they have antibodies that could block gene therapy viruses (AAVs). The goal is to understand how common these antibodies are and which patients might be good candidates…
Phase: NA • Sponsor: Genethon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Could vitamin d levels predict nerve damage in diabetes?
Knowledge-focused Not yet recruitingThis study will measure vitamin D and nerve growth factor levels in 57 men with type 2 diabetes and nerve damage, comparing them to diabetic men without nerve damage and healthy men. Researchers will also test nerve function using electrical studies. The goal is to see if low vit…
Sponsor: Aswan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC